Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Determination is Key in Setting and Achieving Goals in One’s Life and Career

Business professionals, healthcare providers, and college athletes have all made appearances on #WinTheDay with Wasson to showcase their determination. One guest Chase Wasson hasn’t welcomed on the show before is an NFL wide receiver and Olympic Bobsledder, until now. Johnny Quinn is a name people may know. Whether from his days as an NFL football…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Business professionals, healthcare providers, and college athletes have all made appearances on #WinTheDay with Wasson to showcase their determination. One guest Chase Wasson hasn’t welcomed on the show before is an NFL wide receiver and Olympic Bobsledder, until now. Johnny Quinn is a name people may know. Whether from his days as an NFL football player with the Philadelphia Eagles and Green Bay Packers, or as a member of the 2014 Winter Olympics U.S. 4-man bobsleigh team, or from one of his many speaking engagements, Johnny Quinn’s background creates many facets of this inspirational leader.

Chase Wasson got the chance to sit down with Quinn one-on-one to get a first-hand taste of his “win the day” attitude, and Quinn did not disappoint. What did Quinn reveal about his “wind the day” attitude?

Rising to the level of professional football and Olympic athletes doesn’t happen overnight, and it doesn’t happen by accident. It takes tremendous determination, brain training, and overcoming challenges to make it to the pinnacle of sports. Quinn shared some of that journey with Wasson.

“If you can believe it, you can achieve it,” Quinn shared his mother’s favorite motto. “I remember as a young athlete, I wanted to go pro, but I didn’t know in what. So, my parents put me in all the sports. And then I gravitated toward football. At a young age, I started watching many videos on Jerry Rice. I thought, at that age, if you make it to the NFL, you’re a very good football player, until I watched Jerry Rice. Because I would watch his offseason training, his interviews, and there would be other NFL athletes who would go train with Jerry Rice, and they would say, my goodness, I couldn’t keep up with him.”

During Wasson and Quinn’s inspiring conversation, the two discuss…

● Living life with a forward focus

● Unlocking the ‘”it” factor to transform oneself into success

● Dreaming big but using determination to achieve bigger

“I remember getting to the Olympic training center, and here I am, I’m in a new arena, but it’s the same formula,” Quinn said. “I’m going to go observe the gold medal winners. I’m going to observe the Olympians who were Olympians in 2010, 2006, and 2002, who’ve already been to the Olympic games, and what will I do? I’m going to watch their habits. I want to know what time of day they’re lifting. I want to see what styles of lifts; I meant to watch them in the Olympic cafeteria. What are they adding to their plate; what are they passing? I’m doing the same thing I did in football, in a new career that living in Texas, I had no background in.”

About Johnny

Johnny Quinn is an Olympic bobsledder, a highly sought-after speaker for businesses and organizations of all sizes, and the author of Push: Breaking Through the Barriers. Known for thought-provoking and action-packed content, Quinn is a trusted voice on resilience and change management. Some of Quin’s many appearances include ABC, BBC, CNN, ESPN, FOX, TIME, USA Today, and The Wall Street Journal. Quinn speaks on some of the world’s big stages, such as Toyota, Chick-fil-A, Cisco, Wells Fargo, Southwest Airlines, Zillow, Caterpillar, Verizon, and Lockheed Martin. He delivers keynotes, breakout sessions, workshops, training, etc. Each message is handcrafted for the specific audience and is available in person and virtually. Quinn can also accommodate half-day, full-day, and multi-day conferences.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended AstraZeneca and Daiichi Sankyo’s Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly is investing $6.5 billion in a Houston manufacturing facility set to open around 2030, primarily to scale production of Foundayo, its oral GLP-1 treatment. The project signals a broader shift in U.S. pharmaceutical manufacturing reshoring and underscores the supply chain challenge of forecasting demand and building capacity years in advance for breakthrough therapeutics.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain: Lilly's CEO noted that one-third of new GLP-1 pill patients are now choosing Foundayo, illustrating fast-moving market share shifts that complicate production planning years in advance
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

Waiting for perfectly clean data is stalling healthcare AI, not protecting it

Healthcare organizations often delay AI initiatives waiting for perfectly clean data, but this assumption no longer holds: reliable subsets and synthetic data allow projects to start now while data work continues in parallel. Success requires starting with business outcomes rather than technology capabilities, and embedding governance in product strategy before implementation, not after.

  • 01Waiting for 100% clean data is effectively a decision never to start; hospital AI projects can begin on reliable data subsets while quality work continues in parallel.
  • 02Frame AI decisions around business outcomes (revenue growth, cost reduction, competitive advantage, new products, or ecosystem influence) rather than asking what AI can do.
  • 03Governance should be part of product strategy before design or purchase, especially as agentic AI takes actions—such as handling many revenue-cycle denials—while routing the rest to humans.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512